Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD90.2 Rat anti-Mouse, APC-Cy7, Clone: 53-2.1, BD

Rat Monoclonal Antibody

Supplier:  BD Biosciences 561641

Catalog No. BDB561641


Only null left
Add to Cart

Description

Description

The 53-2.1 monoclonal antibody specifically binds to the CD90.2 (Thy-1.2) alloantigen on thymocytes, most peripheral T lymphocytes, some intraepithelial T lymphocytes (IEL, DEC), epithelial cells, fibroblasts, neurons, hematopoietic stem cells, but not B lymphocytes, of most mouse strains. The 53-2.1 antibody has been reported not to crossreact with Thy-1.1 (e.g., AKR/J, PL), or with rat Thy-1. CD90 is a glycophosphatidylinositol-anchored membrane glycoprotein of the Ig superfamily that is involved in signal transduction. In addition, there is evidence that CD90 mediates adhesion of thymocytes to thymic stroma. The 53-2.1 antibody has been reported to block the binding of the Rat Anti-Mouse CD90.2 antibody (Clone 30-H12) to immobilized thymocyte membranes.

TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD90.2
Monoclonal
0.2mg/mL
Thy-1.2; T25; Thymus cell antigen 1, theta
Rat
Affinity Purified
RUO
Mouse
IgG2a κ
Flow Cytometry
53-2.1
APC-Cyanine7
Aqueous buffered solution containing protein stabilizer and ≤0.09% sodium azide.
Mouse Thymus / Spleen
50 μg
Primary
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.